Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

The shift could cut off tens of thousands of people from treatment.

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

UCSF researchers recently gave an overview of their latest work launching a new Institute for HIV Cure Research, funded by a $20 million grant from amfAR, the Foundation for AIDS Research. Cure ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in targeting HIV cells. How do you envision gene therapy working with other forms ...

Researchers revealed on Tuesday that an American, described as a middle-aged woman of mixed race, has likely been cured of HIV after undergoing a new transplant procedure using donated umbilical cord ...

Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...